Cargando…
Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
AIMS: The benefit of the β(1)-adrenergic receptor (β(1)-AR) agonist dobutamine for treatment of acute heart failure in peripartum cardiomyopathy (PPCM) is controversial. Cardiac STAT3 expression is reduced in PPCM patients. Mice carrying a cardiomyocyte-restricted deletion of STAT3 (CKO) develop PPC...
Autores principales: | Stapel, Britta, Kohlhaas, Michael, Ricke-Hoch, Melanie, Haghikia, Arash, Erschow, Sergej, Knuuti, Juhani, Silvola, Johanna M. U., Roivainen, Anne, Saraste, Antti, Nickel, Alexander G., Saar, Jasmin A., Sieve, Irina, Pietzsch, Stefan, Müller, Mirco, Bogeski, Ivan, Kappl, Reinhard, Jauhiainen, Matti, Thackeray, James T., Scherr, Michaela, Bengel, Frank M., Hagl, Christian, Tudorache, Igor, Bauersachs, Johann, Maack, Christoph, Hilfiker-Kleiner, Denise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381590/ https://www.ncbi.nlm.nih.gov/pubmed/28201733 http://dx.doi.org/10.1093/eurheartj/ehw086 |
Ejemplares similares
-
Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages
por: Heimerl, Maren, et al.
Publicado: (2020) -
Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
por: Nonhoff, Justus, et al.
Publicado: (2017) -
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022) -
Peripartum cardiomyopathy: current management and future perspectives
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2015) -
Characterization of peripartum cardiomyopathy by cardiovascular magnetic resonance imaging
por: Haghikia, Arash, et al.
Publicado: (2015)